SEARCH

SEARCH BY CITATION

References

  • 1
    Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 1993; 73: 79118.
  • 2
    Vallee BL, Auld DS. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 1990; 29: 564759.
  • 3
    Chakravarty PK, Ghosh A, Chowdhury JR. Zinc in human malignancies. Neoplasma 1986; 33: 8590.
  • 4
    Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006; 5: 17.
  • 5
    Gupta SK, Singh SP, Shukla VK. Copper, zinc, and Cu/Zn ratio in carcinoma of the gallbladder. J Surg Oncol 2005; 91: 2048.
  • 6
    Margalioth EJ, Schenker JG, Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer 1983; 52: 86872.
  • 7
    Tashiro H, Kawamoto T, Okubo T, Koide O. Variation in the distribution of trace elements in hepatoma. Biol Trace Elem Res 2003; 95: 4963.
  • 8
    Schwartz AE, Leddicotte GW, Fink RW, Friedman EW. Trace elements in normal and malignant human breast tissue. Surgery 1974; 76: 3259.
  • 9
    Mulay IL, Roy R, Knox BE, Suhr NH, Delaney WE. Trace-metal analysis of cancerous and noncancerous human tissues. J Natl Cancer Inst 1971; 47: 113.
  • 10
    Eide DJ. The SLC39 family of metal ion transporters. Pflugers Arch 2004; 447: 796800.
  • 11
    Gaither LA, Eide DJ. Eukaryotic zinc transporters and their regulation. Biometals 2001; 14: 25170.
  • 12
    Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr 2004; 24: 15172.
  • 13
    Palmiter RD, Huang L. Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers. Pflugers Arch 2004; 447: 74451.
  • 14
    Franklin RB, Feng P, Milon B et al. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer 2005; 4: 32.
  • 15
    Manning DL, Robertson JF, Ellis IO et al. Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement. Eur J Cancer 1994; 30A: 6758.
  • 16
    Kasper G, Weiser AA, Rump A et al. Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients. Int J Cancer 2005; 117: 96173.
  • 17
    Kaler P, Prasad R. Molecular cloning and functional characterization of novel zinc transporter, rZip10 (Slc39a10), involved in zinc uptake across rat renal brush border membrane. Am J Physiol Renal Physiol 2007; 292: F21729.
  • 18
    Prasad AS, Kucuk O. Zinc in cancer prevention. Cancer Metastasis Rev 2002; 21: 2915.
  • 19
    Rizk SL, Sky-Peck HH. Comparison between concentrations of trace elements in normal and neoplastic human breast tissue. Cancer Res 1984; 44: 53904.
  • 20
    Tupper R, Watts RW, Wormall A. The incorporation of 65Zn in mammary tumours and some other tissues of mice after injection of the isotope. Biochem J 1955; 59: 2648.
  • 21
    Gupta SK, Shukla VK, Vaidya MP et al. Serum trace elements and Cu/Zn ratio in breast cancer patients. J Surg Oncol 1991; 46: 17881.
  • 22
    Yucel I, Arpaci F, Ozet A et al. Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer. Biol Trace Elem Res 1994; 40: 318.
  • 23
    Kambe T, Yamaguchi-Iwai Y, Sasaki R, Nagao M. Overview of mammalian zinc transporters. Cell Mol Life Sci 2004; 61: 4968.
  • 24
    Yamashita S, Miyagi C, Fukada T, Kagara N, Che YS, Hirano T. Zinc transporter LIVI controls epithelial–mesenchymal transition in zebrafish gastrula organizer. Nature 2004; 429: 298302.
  • 25
    Kabu K, Yamasaki S, Kamimura D et al. Zinc is required for Fc epsilon RI-mediated mast cell activation. J Immunol 2006; 177: 1296305.
  • 26
    Kitamura H, Morikawa H, Kamon H et al. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol 2006; 7: 9717.
  • 27
    Wimmer U, Wang Y, Georgiev O, Schaffner W. Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione. Nucl Acids Res 2005; 33: 571527.